OPRX OptimizeRx Corp

Price (delayed)

$4.56

Market cap

$85.57M

P/E Ratio

12.67

Dividend/share

N/A

EPS

$0.36

Enterprise value

$89.12M

?
Relative Growth: Rel. Growth: 67
Relative Strength: Rel. Strength: 3
Relative Valuation: Rel. Valuation: 96
Relative Profitability: Rel. Profitability: 87

OptimizeRx is a digital health company that provides communications solutions for life science companies, physicians and patients. Connecting over half of healthcare providers in the U.S. and millions of patients ...

Highlights
The net income has surged by 144% year-on-year and by 33% since the previous quarter
OptimizeRx's EPS has soared by 143% YoY and by 29% from the previous quarter

Key stats

What are the main financial stats of OPRX

OPRX stock price

How has the OptimizeRx stock price performed over time
Intraday
-2.56%
1 week
-13.64%
1 month
-7.69%
1 year
-64.87%
YTD
-62.81%
QTD
-27.39%

Financial performance

How have OptimizeRx's revenue and profit performed over time
Revenue
$107.35M
Gross profit
$75.18M
Operating income
$14.2M
Net income
$6.84M
Gross margin
70%
Net margin
6.4%
The net income has surged by 144% year-on-year and by 33% since the previous quarter
The net margin has surged by 139% year-on-year and by 36% since the previous quarter
The gross profit is up by 24% year-on-year and by 2.2% since the previous quarter
OPRX's operating margin is up by 23% since the previous quarter

Price vs fundamentals

How does OPRX's price correlate with its fundamentals

Growth

What is OptimizeRx's growth rate over time

Valuation

What is OptimizeRx stock price valuation
P/E
12.67
P/B
0.66
P/S
0.8
EV/EBIT
6.05
EV/EBITDA
4.68
EV/Sales
0.83
OptimizeRx's EPS has soared by 143% YoY and by 29% from the previous quarter
The price to book (P/B) is 79% less than the 5-year quarterly average of 3.2 and 66% less than the last 4 quarters average of 2.0
OPRX's equity is up by 11% year-on-year
The stock's P/S is 87% below its 5-year quarterly average of 6.2 and 64% below its last 4 quarters average of 2.3
OPRX's revenue is up by 14% year-on-year

Efficiency

How efficient is OptimizeRx business performance
The return on assets has surged by 144% year-on-year and by 33% since the previous quarter
The return on equity has surged by 142% year-on-year and by 31% since the previous quarter
OptimizeRx's ROS has increased by 22% from the previous quarter
The ROIC is up by 21% since the previous quarter

Dividends

What is OPRX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for OPRX.

Financial health

How did OptimizeRx financials performed over time
The current ratio has soared by 90% YoY and by 77% from the previous quarter
OptimizeRx's quick ratio has surged by 86% YoY and by 74% QoQ
The debt is 82% smaller than the equity
OPRX's debt to equity is down by 36% year-on-year and by 10% since the previous quarter
The debt has declined by 28% year-on-year and by 9% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.